Author:
Heider Ulrike,Sezer Orhan
Reference47 articles.
1. The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features;Braziel;Blood,2001
2. IMVP-16: an effective regimen for patients with lymphoma who have relapsed after initial combination chemotherapy;Cabanillas;Blood,1982
3. Report of the Committee on Hodgkin's Disease Staging Classification;Carbone;Cancer Res.,1971
4. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study;Coiffier;Blood,1998
5. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;New Engl. J. Med.,2002